Impfstoffe gegen Coronaviren
EP4577236
Art A1
2. Juli 2025
Anmelder: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Government of the United States, as represented by the Secretary of the Army, Sanofi Pasteur, Inc., United States of America, as represented by the Secretary, Department of Health and Human Services 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4577236
- Aktenzeichen
- EP23768415
- Anmeldetag
- 18. August 2023
- Veröffentlichung
- 2. Juli 2025
- Rechtsraum
- EP
- IPC
- A61K39/12C12N7/00A61K47/00
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
The Government of the United States, as represented by the Secretary of the Army
Sanofi Pasteur, Inc.
United States of America, as represented by the Secretary, Department of Health and Human Services - Land
- 🇺🇸 USA
🇺🇸
United States Department of Health and Human Services
US-Bundesministerium, das über seine Behörden (u.a. NIH) medizinische Forschung fördert und daraus resultierende Patente im Namen der US-Regierung hält.
391 Patente in unserer Datenbank